Tuberculosis in the developing world: recent advances in diagnosis with special consideration of extensively drug-resistant tuberculosis.
Tuberculosis in the developing world: recent advances in diagnosis with special consideration of extensively drug-resistant tuberculosis.
复制标题
DOI:
10.1097/qco.0b013e32830ce783
复制
发表时间:
2008-10
影响因子:
3.9
通讯作者:
Moore DA
中科院分区:
文献类型:
--
作者:
Grandjean L;Moore DA
Globally tuberculosis is mainly diagnosed by sputum smear microscopy, which fails to detect half of all cases and fails to identify drug resistance. Inadequate global TB control through the DOTS strategy alone plus the growing threat of MDR and XDRTB has driven recent development of new commercial and non-commercial tests, which are most desperately needed in resource-limited, high-burden settings. This review outlines the range of options currently available, highlighting particularly those recent developments with greatest potential for addressing the growing MDR and XDR disaster as it affects those communities least technically and financially capable of controlling it. Simplification of molecular diagnostic techniques, rapid liquid culture and the use of colorimetric indicators have improved the sensitivity, speed and reliability of TB and MDRTB detection, while decreasing cost and bringing diagnosis closer towards (though still some way from) the point-of-care. Global TB control in 2008 demands the use of new tools for more sensitive and rapid detection of active disease and of drug resistance. Improved technologies are available for reference laboratories but for settings where resources and technical capacity are limited there is little ready for field implementation. The pipeline is promising, but in the interim wider use of liquid culture and manual or colorimetric DST should be promoted.